Sermorelin/GHRP-6 Injection 6 mg-3 mg Lyophylized I recalled over sterility concerns

Recall date

August 1, 2016

Source

U.S. Food & Drug Administration (FDA) — enforcement report

Official notice title

Town and Country Compounding and Consultation Services recalls Sermorelin/GHRP-6 Injection 6 mg-3 mg Lyophylized I, 2 mL vial, Rx, Town and Country Compounding and Consultation Servi…

Recall number

D-0228-2017

FDA classification

Class I

Brand / firm

Town and Country Compounding and Consultation Services

Sold / distributed

MA, NY, NJ & FL; Canada

Why it was recalled

Non-Sterility; microbial contamination identified as Bacillus circulans

Class I is the FDA’s most serious recall level: there is a reasonable probability that using this product will cause serious harm or death.

What was recalled

Sermorelin/GHRP-6 Injection 6 mg-3 mg Lyophylized I, 2 mL vial, Rx, Town and Country Compounding and Consultation Services, Ridgewood, NJ 074502